Bio-Tissue Hosts Key Educational Events at the American Academy of Ophthalmology Meeting
Prominent speakers to discuss advances in ocular surface treatments
MIAMI, Fla., November 8, 2012 – Bio-Tissue, Inc., an ophthalmic biological therapeutics company, will host key educational events highlighting advances in ocular surface treatments at this year’s American Academy of Ophthalmology Meeting (AAO) taking place November 10-13, 2012 in Chicago.
Bio-Tissue will host an Ocular Surface Biologics Symposium Event “New Therapeutic Strategies to Address Chronic and Acute Ocular Surface and Corneal Conditions,” on Sunday, November 11 from 5:30 p.m. – 6:30 p.m. at the Hyatt Regency. The prominent speakers will be Neel Desai, MD, Eye Institute of West Florida; Daniel A. Johnson, MD, FACS; UT Medicine Eye Clinic at the MARC; and W. Barry Lee, MD, Eye Consultants of Atlanta.
In addition, Bio-Tissue will host a series of presentations by leaders in the field for the treatment of ocular surface diseases and conditions. Presentations will take place throughout the show in Bio-Tissue’s booth #4340, and will cover topics such as “The Emerging Standard of Care for Ocular Surface Diseases,” by Neel Desai, MD, and “Conjunctivochalasis: Restoring the Tear Reservoir,” by Scheffer C.G. Tseng, MD, PhD, Founder of TissueTech, Inc. and Medical Director of Ocular Surface Center and Ocular Surface Research & Education Foundation.
“There are numerous innovative technology and clinical advances being made in the treatment of ocular surface diseases and conditions that are helping to increase surgical efficiency and restore vision,” said Amy Tseng, President and CEO, Bio-Tissue, Inc. “We are pleased to offer such a distinguished panel of speakers during this year’s AAO in Chicago to provide important updates on emerging treatments, research and clinical advances.“